Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses

OBJECTIVES: Many of the cost-effectiveness analyses of apixaban against warfarin focused on Western populations but Asian evidence remains less clear. The present study aims to evaluate the cost-effectiveness of apixaban against warfarin in Chinese patients with non-valvular atrial fibrillation (NVA...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue, Tse, Vicki C., Lau, Wallis C. Y., Cheung, Bernard M. Y., Lip, Gregory Y. H., Wong, Ian C. K., Chan, Esther W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928891/
https://www.ncbi.nlm.nih.gov/pubmed/27362421
http://dx.doi.org/10.1371/journal.pone.0157129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928891/
https://www.ncbi.nlm.nih.gov/pubmed/27362421
http://dx.doi.org/10.1371/journal.pone.0157129

Ejemplares similares